Institutional investors purchased a net $1.8 million shares of PBYI during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 94.55% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCIPAL MANAGEMENT CORP. Bought 2.2 Thousand shares of Puma Biotechnology Inc
FRANKLIN STREET ADVISORS, INC. Bought 980.00 shares of Puma Biotechnology Inc